96 filings
8-K
COLL
Collegium Pharmaceutical Inc
24 May 24
Departure of Directors or Certain Officers
4:05pm
8-K
COLL
Collegium Pharmaceutical Inc
20 May 24
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
COLL
Collegium Pharmaceutical Inc
13 May 24
Other Events
8:05am
8-K
COLL
Collegium Pharmaceutical Inc
10 May 24
Departure of Directors or Certain Officers
8:02am
8-K
COLL
Collegium Pharmaceutical Inc
9 May 24
Collegium Reports First Quarter 2024 Financial Results
4:04pm
8-K
rq0ueew589l16jd2
29 Apr 24
Entry into a Material Definitive Agreement
8:05am
8-K
t8nc5rdemjvld4rj
11 Apr 24
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
8:00am
8-K
ara7iamj aomscg
22 Feb 24
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
4:01pm
8-K
qq7khm z830
3 Jan 24
Regulation FD Disclosure
8:03am
8-K
wxgeyvvw
9 Nov 23
Other Events
8:05am
8-K
mmgmm1szmx
7 Nov 23
Collegium Reports Third Quarter 2023 Financial Results
4:01pm
8-K
ecjex3iumzew
24 Aug 23
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
8:05am
8-K
fva mbp51
7 Aug 23
Other Events
7:40am
8-K
g5u3iu5t
3 Aug 23
Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year
4:03pm
8-K
q4h2 uvm3dflv
19 May 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
jakyj85 k6fb
4 May 23
Collegium Reports First Quarter 2023 Financial Results
4:01pm
8-K
ddgv45vwdzwcuifbbc
23 Feb 23
Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results
4:01pm
8-K
sepjms nha
13 Feb 23
Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
4:05pm
8-K
odnrrct01d3j m3
6 Feb 23
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
4:14pm
8-K
fkkra4aljx5
4 Jan 23
Regulation FD Disclosure
8:04am